Gables Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.7K | Hold |
500
| – | – | 0.02% | 248 |
|
|
2026
Q1 | $35.9K | Hold |
500
| – | – | 0.02% | 255 |
|
|
2025
Q4 | $39.7K | Hold |
500
| – | – | 0.02% | 242 |
|
|
2025
Q3 | $37.7K | Hold |
500
| – | – | 0.02% | 240 |
|
|
2025
Q2 | $34.5K | Sell |
500
-165
| -25% | -$10.8K | 0.02% | 241 |
|
|
2025
Q1 | $45.1K | Hold |
665
| – | – | 0.02% | 220 |
|
|
2024
Q4 | $29.9K | Hold |
665
| – | – | 0.01% | 253 |
|
|
2024
Q3 | $41.8K | Sell |
665
-764
| -53% | -$44.6K | 0.02% | 226 |
|
|
2024
Q2 | $84.4K | Buy |
1,429
+150
| +12% | +$9.38K | 0.04% | 167 |
|
|
2024
Q1 | $102K | Sell |
1,279
-63
| -5% | -$4.81K | 0.06% | 154 |
|
|
2023
Q4 | $106K | Buy |
1,342
+165
| +14% | +$11.7K | 0.07% | 145 |
|
|
2023
Q3 | $82.2K | Hold |
1,177
| – | – | 0.06% | 155 |
|
|
2023
Q2 | $81.4K | Hold |
1,177
| – | – | 0.05% | 161 |
|
|
2023
Q1 | $87.5K | Buy |
1,177
+63
| +6% | +$5.28K | 0.06% | 153 |
|
|
2022
Q4 | $104K | Buy |
1,114
+100
| +10% | +$9.65K | 0.08% | 143 |
|
|
2022
Q3 | $97K | Hold |
1,014
| – | – | 0.08% | 143 |
|
|
2022
Q2 | $94K | Hold |
1,014
| – | – | 0.07% | 148 |
|
|
2022
Q1 | $103K | Hold |
1,014
| – | – | 0.06% | 155 |
|
|
2021
Q4 | $105K | Buy |
1,014
+50
| +5% | +$4.62K | 0.06% | 155 |
|
|
2021
Q3 | $82K | Hold |
964
| – | – | 0.05% | 169 |
|
|
2021
Q2 | $80K | Sell |
964
-90
| -9% | -$7.37K | 0.05% | 167 |
|
|
2021
Q1 | $79K | Hold |
1,054
| – | – | 0.04% | 178 |
|
|
2020
Q4 | $72K | Hold |
1,054
| – | – | 0.04% | 175 |
|
|
2020
Q3 | $62K | Hold |
1,054
| – | – | 0.04% | 177 |
|
|
2020
Q2 | $68K | Buy |
1,054
+100
| +10% | +$6.3K | 0.05% | 164 |
|
|
2020
Q1 | $57K | Buy |
954
+200
| +27% | +$13.4K | 0.05% | 173 |
|
|
2019
Q4 | $56K | Hold |
754
| – | – | 0.04% | 192 |
|
|
2019
Q3 | $47K | Hold |
754
| – | – | 0.03% | 206 |
|
|
2019
Q2 | $41K | Hold |
754
| – | – | 0.03% | 198 |
|
|
2019
Q1 | $41K | Sell |
754
-18
| -2% | -$1.11K | 0.03% | 202 |
|
|
2018
Q4 | $51K | Buy |
772
+332
| +75% | +$24.8K | 0.04% | 174 |
|
|
2018
Q3 | $35K | Sell |
440
-100
| -19% | -$7.15K | 0.03% | 213 |
|
|
2018
Q2 | $35K | Sell |
540
-945
| -64% | -$62.3K | 0.03% | 212 |
|
|
2018
Q1 | $92K | Buy |
+1,485
| New | +$107K | 0.08% | 145 |
|
Other funds holding CVS
Gables Capital Management's CVS Position: Q2 2026 in Review
Gables Capital Management held its CVS Health (CVS) position steady in Q2 2026 at 500 shares worth $51.7K. The position accounts for 0.02% of the portfolio, ranked #248.
Gables Capital Management first reported a position in CVS in Q1 2018 and has held it in 34 quarters since. The position peaked at $106K in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Gables Capital Management held 500 shares of CVS Health worth $51.7K as of Q2 2026.
- Gables Capital Management left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.02% of Gables Capital Management's portfolio in Q2 2026, its #248 holding.
- Gables Capital Management first reported a position in CVS Health in Q1 2018 and has held it in 34 quarters since.
- Gables Capital Management's CVS Health position peaked at $106K in Q4 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.